title: Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.
authors.affiliation: Department of Medicine, Division of Hematology/Oncology, San Francisco Veterans Affairs Medical Center, San Francisco, California.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Mannis
authors.forename: Davina
authors.initials: D
authors.lastname: Wu
authors.forename: Tiffany
authors.initials: T
authors.lastname: Dea
authors.forename: Theodora
authors.initials: T
authors.lastname: Mauro
authors.forename: Gerald
authors.initials: G
authors.lastname: Hsu
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D000493:Allopurinol / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002872:Chromosome Deletion; D002886:Chromosomes, Human, Pair 17; D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D010880:Piperidines; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D058496:Smith-Magenis Syndrome
chemical_list: D000963:Antimetabolites; D000970:Antineoplastic Agents; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000493:Allopurinol; D000225:Adenine